Frontier Biotechnologies Inc. (SHSE: 688221)
Health Care · Biotechnology · CN
CN¥15.85
-6.05% today · +14.1% 1Y
Frontier Biotechnologies Inc. (SHSE: 688221) operates in the Biotechnology industry within the Health Care sector. The company is valued at $886.38M.
Over the last twelve months the share price has gained 14.1%, trading between 13.06 and 29.98.
Tweenvest scores Frontier Biotechnologies Inc. across four factors: quality 40/100, value 49/100, growth 58/100. Its strongest factor is growth.
688221 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $886.38M
- Revenue (TTM)
- $55.65M
- P/E
- —
- EPS
- -0.06
- Dividend yield
- —
- Beta (5Y)
- 0.87
- 52-week high
- CN¥29.98
- 52-week low
- CN¥13.06
- Avg volume (3M)
- —
- Shares outstanding
- 374.58M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Rigel Pharmaceuticals, Inc.NasdaqGS: RIGL | $916.81M | $48.85 | -0.47% |
| Jade Biosciences, Inc.NasdaqCM: JBIO | $915.17M | $14.01 | -2.64% |
| Odyssey Therapeutics, Inc.NasdaqCM: ODTX | $910.45M | $18.28 | -3.79% |
| Alphamab OncologySEHK: 9966 | $907.71M | HK$7.36 | -11.44% |
| Corvus Pharmaceuticals, Inc.NasdaqGM: CRVS | $884.95M | $10.04 | -4.56% |
| Beijing SL Pharmaceutical Co., Ltd.SZSE: 002038 | $883.46M | CN¥5.76 | +0.17% |
| Monte Rosa Therapeutics, Inc.NasdaqGS: GLUE | $878.73M | $10.54 | +2.28% |
| Lepu Biopharma Co., Ltd.SEHK: 2157 | $878.35M | HK$3.82 | -5.56% |
Figures last refreshed Oct 11, 2026.